Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01447290 · ClinicalTrials.gov registry record

Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia

A clinical trial, sponsored by Mike O'Callaghan Military Hospital.

Completed
Registry status
100
Enrollment target

NCT01447290: Completed study, sponsored by Mike O'Callaghan Military Hospital.

NCT01447290 is a clinical trial that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01447290 has completed, sponsored by Mike O'Callaghan Military Hospital.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

This is a non-inferiority, prospective study of the relationship between the 24-hour urine protein collection and spot protein:creatinine ratio in the diagnosis of preeclampsia involving a sample of 18-45 year-old pregnant women attending the new Obstetrics orientation. The investigators will follow all participants who consent to be part of this study throughout their entire pregnancy. Those who get evaluated for preeclampsia will then have a P:C ratio anytime their Primary Obstetrics provider orders a standard of care 24-hour urine collection (standard of care). Those participants who are not evaluated for preeclampsia during their pregnancy will be dropped from the study. Participants evaluated for preeclampsia during the prenatal period will be asked to provide a random spot clean-catch urine sample at intervals of approximately 0 and 24 hours following the initiation of the 24-hour urine collection. The patient's demographic and clinical data, as well as the spot protein:creatinine ratio and 24-hour urine protein will be collected and analyzed at the conclusion of the study period.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-05
Est. Completion 2014-10
Mike O'Callaghan Military Hospital

26 total trials

What the finished NCT01447290 record still lists

NCT01447290 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01447290 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01447290 about?

NCT01447290 is a clinical study titled "Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia". This is a non-inferiority, prospective study of the relationship between the 24-hour urine protein collection and spot protein:creatinine ratio in the diagnosis of preeclampsia involving a sample of 18-45 year-old pregnant women attending the new Obstetrics orientation. The investigators will follow...

What is the current status of trial NCT01447290?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2012-05. Estimated completion is 2014-10.

Who is sponsoring clinical trial NCT01447290?

This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01447290, the US trial registry maintained by the National Library of Medicine. NCT01447290 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.